The approval of immune checkpoint inhibitors (ICI) for metastatic melanoma in 2011 has changed the treatment landscape of this disease.
Scientific Publications
Expression of DNA methyltransferase 1 is a hallmark of melanoma, correlates with response to B-Raf and MEK inhibition and with proliferation in melanocytic tumors
This research was intended to evaluate the expression of DNA methyltransferase 1 is a hallmark of melanoma, associates with the response to B-Raf and MEK inhibition and with proliferation in melanocytic tumors.
Predictors of Long-term Anxiety and Depression in Uveal Melanoma Survivors: A Cross-lagged Five-year Analysis
Cancer survivors commonly experience long-term anxiety and depression.
The Impact of Demographics, Socioeconomics, and Healthcare Access on Melanoma Outcomes
Disparities in provider type, patient demographics, place of residence, insurance status, socioeconomic status (SES), race/ethnicity and age impact melanoma outcomes.